secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001213900-25-060349
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus CFO Yasushi Nagasaki resigns effective June 30, 2025; Hiroko Huynh promoted to CAO
--------------------------------------------------------------------------------

- Yasushi Nagasaki resigned as CFO, effective June 30, 2025, transitioning to full retirement.
- Hiroko Huynh promoted to Chief Accounting Officer effective July 1, 2025.
- Ms. Huynh, previously Controller since Jan 2020, joined Emmaus in Oct 2018 from Deloitte & Touche LLP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390025060349/0001213900-25-060349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390025060349/ea024660801-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-060349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer